IFNA1 and rheumatoid arthritis: Studies have shown that enhanced autoimmune responses can be detected in the presence of disease treated with IFN-α (163) and that 34% of patients have elevated rheumatoid factors (164), and that IFN-α treatment can contribute to the progression of RA (165, 166).